Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-03-07

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1128/JVI.02360-06PMID 17344287PMCID PMC1900280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reverse Genetics of The Largest RNA Viruses

  2008cited by this paper
• Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.

  2007cited by this paper
• Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers

  2006cited by this paper
• RNA Recognition and Cleavage by the SARS Coronavirus Endoribonuclease

  2006cited by this paper
• Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

  2006cited by this paper
• Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti‐viral activity†

  2006cited by this paper
• VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice

  2006cited by this paper
• Peptic ulcer disease today

  2006cited by this paper
• Characterization of the antiviral effects of interferon-α against a SARS-like coronoavirus infection in vitro

  2006cited by this paper
• Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

  2006cited by this paper
• Nidovirus transcription: how to make sense...?

  2006cited by this paper
• Suppression of porcine reproductive and respiratory syndrome virus replication by morpholino antisense oligomers

  2006cited by this paper
• Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure.

  2006cited by this paper
• Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry Site

  2006cited by this paper
• Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers

  2005cited by this paper
• Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

  2005cited by this paper
• Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication

  2005cited by this paper
• Inhibition, Escape, and Attenuated Growth of Severe Acute Respiratory Syndrome Coronavirus Treated with Antisense Morpholino Oligomers

  2005cited by this paper
• Bats Are Natural Reservoirs of SARS-Like Coronaviruses

  2005cited by this paper
• Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.

  2005influential reference
• Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture.

  2005cited by this paper
• Murine Coronavirus Evolution In Vivo: Functional Compensation of a Detrimental Amino Acid Substitution in the Receptor Binding Domain of the Spike Glycoprotein

  2005cited by this paper
• Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.

  2005cited by this paper
• Antisense Morpholino-Oligomers Directed against the 5′ End of the Genome Inhibit Coronavirus Proliferation and Growth†

  2004cited by this paper
• Infectious diseases. Mounting lab accidents raise SARS fears.

  2004cited by this paper
• Laboratory Diagnosis of Four Recent Sporadic Cases of Community-acquired SARS, Guangdong Province, China

  2004cited by this paper
• Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

  2004cited by this paper
• Identification of a new human coronavirus

  2004cited by this paper
• Severe Acute Respiratory Syndrome Coronavirus Phylogeny: toward Consensus

  2004cited by this paper
• The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain

  2003cited by this paper
• Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers.

  2003cited by this paper
• HIV Tat Peptide Enhances Cellular Delivery of Antisense Morpholino Oligomers

  2003cited by this paper
• Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China

  2003cited by this paper
• Morpholino oligos: making sense of antisense?

  2002cited by this paper
• Systemically delivered antisense oligomers upregulate gene expression in mouse tissues

  2002cited by this paper
• Morpholino antisense oligomers: the case for an RNase H-independent structural type.

  1999cited by this paper
• Morpholino Antisense Oligomers: Design, Preparation, and Properties

  1997cited by this paper
• Murine coronavirus infection: a paradigm for virus-induced demyelinating disease

  1997cited by this paper
• Activation of the Immune Coagulation System by Murine Hepatitis Virus Strain 3

  1989cited by this paper
• Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus

  1989cited by this paper
• 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

  1987cited by this paper

• Development of a two-dimensional liquid chromatography/mass spectrometry workflow for characterization of phosphorodiamidate morpholino oligomers.

  2025cites this paper
• Sequencing of Phosphorodiamidate Morpholino Oligomers by Hydrophilic Interaction Chromatography Coupled to Tandem Mass Spectrometry

  2024cites this paper
• Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA

  2024cites this paper
• Antisense oligonucleotides: a promising therapeutic option against infectious diseases

  2023cites this paper
• Antisense oligonucleotide based therapeutics and its applications against bacterial infections

  2023cites this paper
• Small-molecule oligonucleotides as smart modality for antiviral therapy: a medicinal chemistry perspective.

  2023cites this paper
• Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus

  2023cites this paper
• Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies

  2023cites this paper
• Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives

  2023cites this paper
• Antisense oligonucleotides: recent progress in the treatment of various diseases

  2022cites this paper
• Synthesis of Phosphorodiamidate Morpholino Oligonucleotides Using Trityl and Fmoc Chemistry in an Automated Oligo Synthesizer.

  2022cites this paper
• Automated Fast-Flow Synthesis of Peptide Nucleic Acid Conjugates

  2021cites this paper
• Automated Flow Synthesis of Peptide–PNA Conjugates

  2021cites this paper
• Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs

  2021cites this paper
• Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

  2021cites this paper
• Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino-oligomers

  2020cites this paper
• Peptide Conjugated Morpholinos for Management of The Huanglongbing Pathosystem.

  2020cites this paper
• Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs)

  2020cites this paper
• Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers

  2020cites this paper
• Potential Opportunity of Antisense Therapy of COVID-19 on an in Vitro Model

  2020cites this paper
• Advances in oligonucleotide drug delivery

  2020cites this paper
• Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers for In Situ Live-Cell Molecular Imaging of Dengue Virus Replication

  2020cites this paper
• Nucleic Acid-Based Technologies Targeting Coronaviruses

  2020influential citation
• Automated Fast-Flow Synthesis of Antisense Phosphorodiamidate Morpholino Oligomers

  2020cites this paper
• Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers

  2020cites this paper
• Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds

  2018influential citation
• Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics

  2018cites this paper
• The host microRNA miR-301a blocks the IRF1-mediated neuronal innate immune response to Japanese encephalitis virus infection

  2017cites this paper
• Aggregation and Disaggregation of Morpholino Oligomers in Solution.

  2017cites this paper
• Molecular Biology and Infection of Hepatitis E Virus

  2016cites this paper
• Peptides for nucleic acid delivery.

  2016cites this paper
• Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.

  2015cites this paper
• Delivery of therapeutic oligonucleotides with cell penetrating peptides☆

  2015cites this paper
• Targeting NF-κB subunits p50 and p65 in chroniclymphocytic leukaemia with cell penetrating peptides

  2014cites this paper
• Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

  2014cites this paper
• Synthesis and Antiviral Properties of Spirocyclic [1,2,3]‐Triazolooxazine Nucleosides

  2014cites this paper
• Is there a future for cell-penetrating peptides in oligonucleotide delivery?

  2013cites this paper
• In vivo delivery of morpholino oligos by cell-penetrating peptides.

  2013cites this paper
• Antisense antivirals: future oligonucleotides-based therapeutics for viral infectious diseases

  2013cites this paper
• Host factors in nidovirus replication

  2013cites this paper
• Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides

  2013cites this paper
• Advanced morpholino oligomers: A novel approach to antiviral therapy

  2012influential citation
• Use of cell-penetrating-peptides in oligonucleotide splice switching therapy.

  2012cites this paper
• Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA

  2012cites this paper
• Title : In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides

  2012cites this paper
• Seroprevalence of Dengue 2 Virus Infection in Patients Presenting with Febrile Illness in Selected Health Facilities in Trans Nzoia Region, Kenya, 2009

  2012cites this paper
• Cell-penetrating peptides for the delivery of nucleic acids

  2012influential citation
• Peptide-Based In Vivo Delivery Agents for Oligonucleotides and siRNA

  2012cites this paper
• INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CELL CULTURES AND IN MICE WITH MORPHOLINO OLIGOMERS

  2011cites this paper
• Inhibition of Primary Effusion Lymphoma Engraftment in Scid Mice by Morpholino Oligomers against Early Lytic Genes of Kaposi'S Sarcoma-Associated Herpesvirus

  2011cites this paper
• Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.

  2011cites this paper
• TAAVI LEHTO Delivery of nucleic acids by cell-penetrating peptides: application in modulation of gene expression

  2011cites this paper
• Development of Peptide-Conjugated Morpholino Oligomers as Pan-Arenavirus Inhibitors

  2011cites this paper
• Cell-Penetrating Peptides for Antiviral Drug Development

  2010influential citation
• Curing of HeLa cells persistently infected with equine arteritis virus by a peptide-conjugated morpholino oligomer

  2010cites this paper
• In vivo biodistribution and efficacy of peptide mediated delivery.

  2010cites this paper
• The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.

  2010cites this paper
• Molecular Mechanism of Parvovirus Infection

  2010cites this paper
• Cell penetrating peptides: overview and applications to the delivery of oligonucleotides

  2010cites this paper
• Targeting Host E-Selectin Expression by Antisense Oligodeoxynucleotides as Potential Antiendotoxin Therapy In Vivo

  2010cites this paper
• Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer

  2010cites this paper
• Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.

  2009cites this paper
• Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

  2009cites this paper
• Title : Investigation of Cis-acting RNA Element Role in Bovine Viral Diarrhea Virus Replication

  2009cites this paper
• Gene Knockdowns in Adult Animals: PPMOs and Vivo-Morpholinos

  2009cites this paper
• Enhanced inhibition of porcine reproductive and respiratory syndrome virus replication by combination of morpholino oligomers

  2009cites this paper
• Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses

  2009cites this paper
• Inhibition of Intracellular Growth of Salmonella enterica Serovar Typhimurium in Tissue Culture by Antisense Peptide-Phosphorodiamidate Morpholino Oligomer

  2009cites this paper
• Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.

  2009cites this paper
• A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of Picornavirus

  2008cites this paper
• Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers

  2008influential citation
• Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function

  2008cites this paper
• Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice.

  2008cites this paper
• Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies

  2008cites this paper
• Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers.

  2008cites this paper
• Yellow Head Virus: Transmission and Genome Analyses

  2008cites this paper
• Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.

  2008cites this paper
• Inhibition of PRRSV Replication by Combination of Antisense Morpholino Oligomers

  2008cites this paper
• Wechselwirkungen von SARS-Coronavirus mit zellulären Abwehrmechanismen

  2008cites this paper
• Blockade of viral interleukin-6 expression of Kaposi's sarcoma–associated herpesvirus

  2008cites this paper
• Inhibition of norovirus replication by morpholino oligomers targeting the 5′-end of the genome

  2008cites this paper
• Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers

  2008cites this paper
• Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus

  2008cites this paper
• Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses

  2008cites this paper
• Title of Document : INHIBITION OF PRRSV REPLICATION BY COMBINATION OF ANTISENSE MORPHOLINO OLIGOMERS

  2008cites this paper
• Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues.

  2008cites this paper
• Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino Oligomers

  2007cites this paper
• Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication

  2007cites this paper
• Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.

  2007cites this paper
• Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.

  2007cites this paper
• Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity

  2007cites this paper
• Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.

  2007cites this paper
• Cell penetrating peptide conjugates of steric block oligonucleotides

  2007cites this paper
• MIT Open Access Articles Advances in oligonucleotide drug delivery

  year unknowncites this paper